Three Mechanistically Distinct Kinase Assays Compared: Measurement of Intrinsic ATPase Activity Identified the Most Comprehensive Set of ITK Inhibitors

Braunwalder, 1996, Measurement of the protein tyrosine kinase activity of c-src using time-resolved fluorometry of europium chelates., Anal Biochem, 238, 159, 10.1006/abio.1996.0269

Park, 1999, Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence., Anal Biochem, 269, 94, 10.1006/abio.1999.4029

Von Leoprechting, 2004, Miniaturization and validation of a high-throughput serine kinase assay using the alpha screen platform., J Biomol Screen, 9, 719, 10.1177/1087057104268805

Biazzo-Ashnault, 2001, Detection of insulin receptor tyrosine kinase activity using time-resolved fluorescence energy transfer technology., Anal Biochem, 291, 155, 10.1006/abio.2001.5027

Seethala, 1997, A homogeneous, fluorescence polarization assay for src-family tyrosine kinases., Anal Biochem, 253, 210, 10.1006/abio.1997.2365

Sportsman, 2004, Immobilized metal ion affinity-based fluorescence polarization (IMAP): advances in kinase screening., Assay Drug Dev Technol, 2, 205, 10.1089/154065804323056549

Rodems, 2002, A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases., Assay Drug Dev Technol, 1, 9, 10.1089/154065802761001266

Morgan, 2004, Development and validation of a fluorescence technology for both primary and secondary screening of kinases that facilitates compound selectivity and site-specific inhibitor determination., Assay Drug Dev Technol, 2, 171, 10.1089/154065804323056512

Singh, 2004, Identification of kinase inhibitors by an ATP depletion method., Assay Drug Dev Technol, 2, 161, 10.1089/154065804323056503

Koresawa, 2004, High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase., Assay Drug Dev Technol, 2, 153, 10.1089/154065804323056495

Kolb, 1998, Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence., Drug Discov Today, 3, 333, 10.1016/S1359-6446(98)01204-5

Krebs, 1958, The muscle phosphorylase b kinase reaction., J Biol Chem, 231, 73, 10.1016/S0021-9258(19)77286-X

Chen, 2000, Kinetic mechanism of the p38-alpha MAP kinase: phosphoryl transfer to synthetic peptides., Biochemistry, 39, 2079, 10.1021/bi9919495

Ward, 1992, The intrinsic ATPase activity of protein kinase C is catalyzed at the active site of the enzyme., Biochemistry, 31, 5905, 10.1021/bi00140a029

Mendelow, 1993, ATPase-promoting dead end inhibitors of the cAMP-dependent protein kinase., J Biol Chem, 268, 12289, 10.1016/S0021-9258(18)31387-5

Young, 1997, Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site., J Biol Chem, 272, 12116, 10.1074/jbc.272.18.12116

Noble, 2004, Protein kinase inhibitors: insights into drug design from structure., Science, 303, 1800, 10.1126/science.1095920

Warrior, 1999, Development of a p38 kinase binding assay for high throughput screening., J Biomol Screen, 4, 129, 10.1177/108705719900400306

Vainshtein, 2002, A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP)., J Biomol Screen, 7, 507, 10.1177/1087057102238624

Prokopowicz AS, Brown MP, Wildeson JM, Jakes S, Labadia ME: Fluorescent probes for use in protein kinase inhibitor binding assay. Patent application number 10/955,129, pub. no. US 2005/0100978 A1. Filed Sep 30, 2004.

Gibson, 1993, Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q., Blood, 82, 1561, 10.1182/blood.V82.5.1561.1561

Yamada, 1993, Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells., Biochem Biophys Res Commun, 192, 231, 10.1006/bbrc.1993.1404

Forssell, 2005, Interleukin-2-inducible T cell kinase regulates mast cell degranulation and acute allergic responses., Am J Respir Cell Mol Biol, 32, 511, 10.1165/rcmb.2004-0348OC

O’Reilly, 1992

Dracheva, 1995, Identification of the primase active site of the herpes simplex virus type 1 helicase-primase., J Biol Chem, 270, 14148, 10.1074/jbc.270.23.14148

Pullen, 1998, CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization., Biochemistry, 37, 11836, 10.1021/bi981067q

Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays., J Biomol Screen, 4, 67, 10.1177/108705719900400206

O’Brian, 1990, Characterization of a Ca2(+)- and phospholipid-dependent ATPase reaction catalyzed by rat brain protein kinase C., Biochemistry, 29, 4278, 10.1021/bi00470a003

Pommereau, 2004, Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format., J Biomol Screen, 9, 409, 10.1177/1087057104264175

Wu, 2003, Comparison of assay technologies for a nuclear receptor assay screen reveals differences in the sets of identified functional antagonists., J Biomol Screen, 8, 381, 10.1177/1087057103256466

Sills, 2002, Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening., J Biomol Screen, 7, 191, 10.1177/108705710200700304

Wu, 2005, Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability., J Biomol Screen, 10, 581, 10.1177/1087057105275628

Hubert, 2003, Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors., J Biomol Screen, 8, 399, 10.1177/1087057103255071

Woodward, 2006, Improving the design and analysis of high-throughput screening technology comparison experiments using statistical modeling., J Biomol Screen, 11, 5, 10.1177/1087057105280779

Von Ahsen, 2006, Assay concordance between SPA and TR-FRET in high-throughput screening., J Biomol Screen, 11, 606, 10.1177/1087057106288183

Armstrong, 1979, Cyclic AMP-dependent ATPase activity of bovine heart protein kinase., Proc Natl Acad Sci USA, 76, 722, 10.1073/pnas.76.2.722

Sugden, 1976, Purification and characterization of the catalytic subunit of adenosine 3´: 5´-cyclic monophosphate-dependent protein kinase from bovine liver., Biochem J, 159, 409, 10.1042/bj1590409

Moll, 1976, Phosphorylation of histone catalyzed by a bovine brain protein kinase., J Biol Chem, 251, 3993, 10.1016/S0021-9258(17)33346-X

Lakowicz, 1999

Cousins-Wasti, 1996, Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity., Biochemistry, 35, 16746, 10.1021/bi9620868